Corpus ID: 59427700

Chronic Kidney Disease ( CKD ) prevention or The urgency of a national policy of screening and early treatment

  title={Chronic Kidney Disease ( CKD ) prevention or The urgency of a national policy of screening and early treatment},
  author={H. S{\'a}},
9 Chronic kidney disease (CKD) is one of the chronic diseases of modern societies, such as cardiovascular, oncologic, respiratory and diabetic diseases that can be treated, though not always be cured. It is estimated that over 80% of deaths, in Europe, are caused by these chronic diseases, for which the best investment is prevention. Furthermore, in Portugal, strategies to promote health and prevent disease would be rational, at a time when severe austerity measures are decreed by the… Expand

Tables from this paper

Renal and cardiovascular risk predictive value of two different microalbuminuria screening methods in patients with hypertension with/without diabetes in Portugal
Assessing the renal and cardiovascular risk predictive value of two different microalbuminuria screening methods, nephelometry with 24-h urine (MA-24 h) and Micral test with occasional urine (MicralA), MicralA can be considered as a valid and reliable method for MA screening in patients with HTN with/without T2DM. Expand
Prevalence of self-reported chronic kidney disease in adults in the Metropolitan Region of Manaus: a cross-sectional population-based study, 2015.
Two out of every 100 Manaus metropolitan region inhabitants self-reported chronic kidney disease and it was more frequent in older adults and those who had had strokes. Expand


Benefits of screening for Chronic Kidney Disease.
Screening for CKD could be best managed by partnership between primary care physicians and nephrologists, and the results obtained by screening should be interpreted with caution, bearing in mind that screening detects only markers of kidney disease but not the disease itself. Expand
Early recognition and prevention of chronic kidney disease
Novel clinical methods to better identify patients at risk of progression to later stages of chronic kidney disease, including kidney failure, are needed to target management to high-risk subgroups. Expand
Staging of chronic kidney disease: time for a course correction.
It is suggested that stages 1 and 2 be eliminated and stages 3, 4, and 5, be simply termed moderate impairment, severe impairment, and kidney failure, respectively, to allow identification and treatment of clinically relevant disease and avoidance of what can seem exaggerated prevalence estimates. Expand
Classification of Chronic Kidney Disease in the Elderly: Pitfalls and Errors
A stable low GFR in the elderly, provided it is physiologically sufficient to meet homeostatic demands, is not a disease per se and seldom progresses to true kidney failure, however, it can be a risk factor for acute kidney injury drug misdosing, and possibly cardiovascular disease, so it should be noted. Expand
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.
There was a high prevalence of CVD in CKD and that mortality due to CVD was 10 to 30 times higher in dialysis patients than in the general population, and the task force recommended that patients with CKD be considered in the “highest risk group” for subsequent CVD events. Expand
Prevalence of Chronic Kidney Disease and Associated Risk Factors, and Risk of End-Stage Renal Disease: Data from the PREVADIAB Study
The high incidence of ESRD among the Portuguese population is not due to a greater prevalence of CKD, and a higher rate of progression associated with the high prevalence of risk factors may account for the high incidence. Expand
Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.
The 2006 KDIGO Controversies Conference on CKD was convened to consider six major topics: CKD classification, CKD screening and surveillance, public policy for CKD, CVD and CVD risk factors as risk factors for development and progression of CKd, association of CKD with chronic infections, and (6) association of CJD with cancer. Expand
Screening for CKD with eGFR: doubts and dangers.
Whether early identification and treatment of subjects with "reduced" levels of GFR within the normal range for their age/gender, but without any other manifestations of kidney disease, will reduce the subsequent risk of cardiovascular events or progression to end-stage-renal disease is currently unproven. Expand
Cardiovascular disease in patients with chronic kidney disease
Patients with chronic kidney disease have a high burden of cardiovascular morbidity and mortality. The vast majority of patients with chronic kidney disease do not progress to end stage renalExpand
Dissecting and refining the staging of chronic kidney disease.
A modified definition and staging system of CKD based on the presence of unequivocal, irreversible structural kidney disease, the presence or degree of impairment of kidney function, and the consequences thereof is offered for discussion. Expand